Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Similares en SciELO
Compartir
Gaceta médica de México
versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813
Resumen
CEDILLO-ALVAREZ, Carla et al. COVID-19: a basic approach to understanding potential treatments. Gac. Méd. Méx [online]. 2020, vol.156, n.6, pp.580-585. Epub 27-Mayo-2021. ISSN 2696-1288. https://doi.org/10.24875/gmm.20000452.
SARS-CoV-2 virus has been identified as the causative agent of the COVID-19 pandemic. Even when no standard treatment is available, antivirals such as remdesivir and other drugs such as chloroquine and ivermectin, which interfere with viral replication, have been assayed. Some strategies aimed to reduce immune mechanisms, such as the use of tocilizumab and natural antioxidants, have also been tested. The use of drugs related to the renin-angiotensin system has been controversial. Pathogenicity mechanisms, as well as controlled treatments, still have to be studied in detail in order to propose a viable therapeutic option that prevents the entry and replication of the virus or enhances the host immune system.
Palabras llave : Covid-19; Pharmacological treatments; Renin-angiotensin system.